Development Level

Tclin 15 | 613
Tchem 9 | 1,598
Tbio 8 | 11,445

IMPC Phenotype

preweaning lethality, incomple... 5 | 499
decreased total body fat amoun... 4 | 207
decreased vertical activity 3 | 208
hypoactivity 3 | 132
increased circulating HDL chol... 3 | 80
abnormal behavioral response t... 2 | 66
decreased circulating HDL chol... 2 | 68
decreased lean body mass 2 | 135
decreased lymphocyte cell numb... 2 | 83
embryonic lethality prior to o... 2 | 239
embryonic lethality prior to t... 2 | 278
enlarged heart 2 | 210
increased circulating choleste... 2 | 66
increased lean body mass 2 | 172
increased total body fat amoun... 2 | 134
preweaning lethality, complete... 2 | 979
abnormal behavior 1 | 298
abnormal bone structure 1 | 187
abnormal embryo size 1 | 220
abnormal epididymis morphology 1 | 42
abnormal heart morphology 1 | 162
abnormal sleep behavior 1 | 70
abnormal social-conspecific in... 1 | 3
anophthalmia 1 | 33
decreased anxiety-related resp... 1 | 12
decreased blood urea nitrogen ... 1 | 51
decreased body weight 1 | 161
decreased bone mineral content 1 | 151
decreased bone mineral density 1 | 126
decreased circulating LDL chol... 1 | 38
decreased circulating amylase ... 1 | 28
decreased circulating insulin ... 1 | 76
decreased circulating triglyce... 1 | 79
decreased exploration in new e... 1 | 11
decreased grip strength 1 | 116
decreased leukocyte cell numbe... 1 | 73
decreased mean corpuscular vol... 1 | 79
decreased neutrophil cell numb... 1 | 42
edema 1 | 59
female infertility 1 | 60
hyperactivity 1 | 148
increased bone mineral content 1 | 108
increased bone mineral density 1 | 72
increased circulating LDL chol... 1 | 13
increased circulating alkaline... 1 | 122
increased circulating calcium ... 1 | 34
increased circulating serum al... 1 | 22
increased circulating sodium l... 1 | 71
increased circulating total pr... 1 | 28
increased coping response 1 | 4
increased exploration in new e... 1 | 8
increased fasted circulating g... 1 | 76
increased grip strength 1 | 41
increased heart rate 1 | 23
increased mean corpuscular hem... 1 | 96
increased monocyte cell number 1 | 63
increased neutrophil cell numb... 1 | 46
lordosis 1 | 1
shortened ST segment 1 | 10
thrombocytosis 1 | 27
vertebral transformation 1 | 12

Disease

Carcinoma 31 | 11,493
Schizophrenia 18 | 1,160
Cancer 16 | 2,499
osteosarcoma 16 | 7,950
Depressive disorder 15 | 409
medulloblastoma, large-cell 15 | 6,241
ovarian cancer 15 | 8,520
glioblastoma 14 | 5,792
Alcoholic Intoxication, Chronic 13 | 289
Mental Depression 12 | 333
Attention deficit hyperactivity disorder 11 | 278
ependymoma 11 | 4,679
Kidney cancer 10 | 2,613
Major Depressive Disorder 10 | 301
atypical teratoid / rhabdoid tumor 10 | 5,112
Seizures 9 | 596
Unipolar Depression 9 | 250
adult high grade glioma 9 | 3,801
lung cancer 9 | 4,740
malignant mesothelioma 9 | 3,232
primitive neuroectodermal tumor 9 | 3,035
psoriasis 9 | 6,694
Autistic Disorder 8 | 364
Bipolar Disorder 8 | 666
Breast cancer 8 | 3,578
Cocaine-Related Disorders 8 | 92
Mood Disorders 8 | 184
Obesity 8 | 678
Parkinson's disease 8 | 392
diabetes mellitus 8 | 1,728
group 3 medulloblastoma 8 | 4,104
subependymal giant cell astrocytoma 8 | 2,287
Alcohol dependence 7 | 107
Epilepsy 7 | 792
Intellectual disability 7 | 1,016
Substance abuse 7 | 59
Amphetamine-Related Disorders 6 | 74
Attention Deficit Disorder with Hyperactivity 6 | 21
Autosomal recessive predisposition 6 | 1,442
Cocaine Dependence 6 | 51
ductal carcinoma in situ 6 | 1,745
invasive ductal carcinoma 6 | 2,951
lung adenocarcinoma 6 | 2,716
Anxiety Disorders 5 | 38
Cocaine abuse 5 | 19
Cognitive delay 5 | 608
Constipation 5 | 181
Diarrhea 5 | 253
Global developmental delay 5 | 608
Hyperactive behavior 5 | 91
Mental and motor retardation 5 | 608
Multiple myeloma 5 | 1,332
Nicotine dependence 5 | 54
Opiate dependence 5 | 29
interstitial cystitis 5 | 2,312
non-small cell lung cancer 5 | 2,890
oligodendroglioma 5 | 2,850
Alcohol abuse 4 | 50
Alzheimer's disease 4 | 658
Anxiety disorder 4 | 23
Astrocytoma, Pilocytic 4 | 3,081
Autism spectrum disorder 4 | 101
Conduct disorder 4 | 33
Dull intelligence 4 | 645
Gilles de la Tourette syndrome 4 | 47
Hyperkinesis 4 | 32
Hypertensive disease 4 | 292
Hypotension 4 | 82
Low intelligence 4 | 645
Mental Retardation 4 | 645
Mental deficiency 4 | 645
Migraine 4 | 83
Movement Disorders 4 | 55
Pain 4 | 103
Pain agnosia 4 | 104
Poor school performance 4 | 645
Prostatic Neoplasms 4 | 495
Psychotic Disorders 4 | 151
Short stature 4 | 531
Substance Withdrawal Syndrome 4 | 55
Toxic encephalopathy 4 | 141
intraductal papillary-mucinous neoplasm (IPMN) 4 | 3,291
lung carcinoma 4 | 2,843
obsessive-compulsive disorder 4 | 61
pancreatic cancer 4 | 2,398
Allergic rhinitis 3 | 94
Amyotrophic lateral sclerosis 3 | 451
Cognition Disorders 3 | 32
Hypertension 3 | 396
Melanoma 3 | 711
Neurodegenerative disease 3 | 414
Status Epilepticus 3 | 98
Substance-Related Disorders 3 | 115
Vascular disease 3 | 319
acute quadriplegic myopathy 3 | 1,158
astrocytoma 3 | 1,146
pancreatic carcinoma 3 | 562
pancreatic ductal adenocarcinoma liver metastasis 3 | 1,962
pituitary cancer 3 | 1,972
tuberculosis 3 | 2,010

Tissue

Endocrine System 32 | 18,159
Female tissues 30 | 17,400
Digestive Tract 29 | 17,369
Nervous System 29 | 16,725
Skin and soft tissues 28 | 17,230
Male tissues 27 | 17,142
Respiratory system 27 | 16,393
Liver and Pancreas 26 | 16,750
Blood and immune system 25 | 16,909
Urinary Tract 25 | 16,678
Cardiovascular System 23 | 15,192

Target Family

GPCR 9 | 408
Non-IDG 6 | 12,091
Enzyme 5 | 4,145
Epigenetic 4 | 242
Ion Channel 2 | 344
Kinase 2 | 634
Transcription Factor 2 | 1,400
Transporter 2 | 473

GO Process

response to cocaine 32 | 32
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Neuronal acetylcholine receptor subunit beta-2 CHRNB2 Tclin Ion Channel -1.62448 37.6 174
Histamine N-methyltransferase HNMT Tchem Enzyme -2.88300 757.5 234
Sodium-dependent dopamine transporter SLC6A3 Tclin Transporter -3.59848 3752.4 324
Methyl-CpG-binding domain protein 1 MBD1 Tbio Transcription Factor -2.23809 171.1 297
Cannabinoid receptor 1 CNR1 Tclin GPCR -3.71368 5235.6 431
D(3) dopamine receptor DRD3 Tclin GPCR -2.51699 312.3 189
Pituitary homeobox 3 PITX3 Tbio Transcription Factor -2.26232 188.5 134
116 kDa U5 small nuclear ribonucleoprotein component EFTUD2 Tbio Non-IDG -1.57287 38.6 177
D(1B) dopamine receptor DRD5 Tchem GPCR -2.33008 183.7 304
DNA (cytosine-5)-methyltransferase 3B DNMT3B Tchem Epigenetic -2.73137 480.9 350